TripleHelix Science™
Last Updated: 20th February, 2026
By accessing this website (“Site”), you agree to be bound by these Terms of Use (“Terms”). If you do not agree, you must discontinue use immediately.
1. Informational Purpose Only
TripleHelix Science™ develops investigational gene therapy and biotechnology platforms that may be in research, preclinical, or clinical development stages. This Site is provided for informational and corporate communication purposes only.
Nothing on this Site constitutes:
- Medical advice
- Clinical treatment guidance
- Regulatory approval
- An offer to sell therapeutic products
- An offer or solicitation of securities
- A binding commercial proposal
2. No Medical Relationship
Use of this Site does not create a physician–patient relationship or any therapeutic obligation.
3. Scientific & Regulatory Uncertainty
Biotechnology research involves inherent scientific and regulatory risks. Descriptions of therapeutic platforms, gene therapy technologies, or cellular aging interventions are subject to change and may not receive regulatory approval.
4. Intellectual Property
All content on this Site is protected by international intellectual property laws.No license, express or implied, is granted to use any patents, trade secrets, trademarks, or proprietary technology.
5. Research Restriction
Content may not be reverse engineered, reproduced, or used to develop competing technologies without written authorization.
6. Export Control
Technologies described may be subject to export control and sanctions laws. Users agree to comply with all applicable regulations.
7. Limitation of Liability
To the fullest extent permitted by law, TripleHelix Science™ shall not be liable for any direct, indirect, incidental, or consequential damages arising from use of this Site.
8. Governing Law & Arbitration
These Terms shall be governed by internationally recognized commercial law principles.Disputes shall be resolved through confidential binding arbitration.
9. Modifications
We may update these Terms at any time. Continued use constitutes acceptance.